ArticlePDF Available

Cardiovascular disease (CVD) and its associated risk factors among older adults in India: Evidence from LASI Wave 1

Authors:

Abstract and Figures

Background With the turn of the century, CVDs have become the leading cause of mortality in India. Despite the wide heterogeneous prevalence of risk factors across different regions, CVD is the major cause of death in all parts of India. Therefore, the study aimed to investigate the prevalence of CVDs and its associated risk factors among older adults in India. Methods The current study used data from the LASI, Wave 1, the world's largest and India's first longitudinal aging study. The total sample for the analysis was 65562 (45 and above individuals).Statistical analyses were conducted using STATA SE version 14.The self-reported prevalence of CVDs was calculated by considering any one of the self-reported diagnosed conditions of hypertension, stroke, and chronic heart diseases. Binary Logistic regression was carried out between CVD and its associated risk factors like age, sex, place of residence, physical activity, family history of CVD, Diabetes/blood sugar, high cholesterol. P < 0.05 from two-sided statistical tests was regarded statistically significant. Results The study indicated that the overall self-reported prevalence of diagnosed CVDs was 29.4% for older adults age 45 and above in India. Age was associated with increased risk of CVD Female older adults were more likely to have CVDs than male.The place of residence also had a stronger association with CVDs.In addition, high cholesterol, diabetes and physical inactivity were key risk factors for CVDs.The study also indicated that Family history was associated with a greater perceived risk for CVDs. The greater prevalence of CVDs risk factors among older adults manifested alarming public health concerns and a future health demand. It creates a threat if health promotion and awareness programs are not well designed.
Content may be subject to copyright.
Clinical Epidemiology and Global Health 13 (2022) 100937
Available online 17 December 2021
2213-3984/© 2021 Published by Elsevier B.V. on behalf of INDIACLEN. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
Original article
Cardiovascular disease (CVD) and its associated risk factors among older
adults in India: Evidence from LASI Wave 1
Jhumki Kundu
a
, Sampurna Kundu
a
,
b
,
*
a
International Institute for Population Sciences, Deonar, Mumbai, 400088, India
b
Centre of Social Medicine and Community Health, Jawaharlal Nehru University, Delhi, 110067, India
ARTICLE INFO
Keywords:
CVDs
Risk factors
Older adults
India
ABSTRACT
Background: With the turn of the century, CVDs have become the leading cause of mortality in India. Despite the
wide heterogeneous prevalence of risk factors across different regions, CVD is the major cause of death in all
parts of India. Therefore, the study aimed to investigate the prevalence of CVDs and its associated risk factors
among older adults in India.
Methods: The current study used data from the LASI, Wave 1, the worlds largest and Indias rst longitudinal
aging study. The total sample for the analysis was 65562 (45 and above individuals). The self-reported preva-
lence of CVDs was calculated by considering any one of the self-reported diagnosed conditions of hypertension,
stroke, and chronic heart diseases. Binary Logistic regression was carried out between CVD and its associated risk
factors like age, sex, place of residence, physical activity, family history of CVD, Diabetes/blood sugar, high
cholesterol. P <0.05 from two-sided statistical tests was regarded statistically signicant.
Results: The study indicated that the overall self-reported prevalence of diagnosed CVDs was 29.4% for older
adults age 45 and above in India. Age was associated with increased risk of CVD Female older adults were more
likely to have CVDs than male.The place of residence also had a stronger association with CVDs.In addition, high
cholesterol, diabetes and physical inactivity were key risk factors for CVDs.The study also indicated that Family
history was associated with a greater perceived risk for CVDs. The greater prevalence of CVDs risk factors among
older adults manifested alarming public health concerns and a future health demand. It creates a threat if health
promotion and awareness programs are not well designed.
1. Introduction
India has been experiencing a rapid epidemiological transition in the
last few decades. Along with the increase in life expectancy, there is an
emergence of non-communicable diseases (NCD) which is becoming a
greater public health concern in India. Major four NCDs namely car-
diovascular diseases (CVD), chronic respiratory diseases (CRD), cancers
and Diabetes account for more than 80% of the total premature NCD
deaths .
20
Globally, around 17.9 million people annually die due to
CVDs, followed by cancers (9.3 million), respiratory diseases (4.1
million), and diabetes (1.5 million).
21
More than four out of ve CVD
deaths are due to heart attacks and strokes, and one third of these deaths
occur prematurely in people under 70 years of age.
33
The number of
people with total CVD nearly doubled from 271 million in 1990 to 523
million in 2019, and deaths due to CVD climbed signicantly from 12.1
million in 1990 to 18.6 million in 2019.
28
The majority of NCD deaths occur in low and middle-income coun-
tries including India.
43
As a result of rapid urbanization and change in
lifestyle; the epidemiological health transition has taken place; which
has led to an overall economic rise, but with certain associated ipsides
(risk factors).With growing burden of NCDs and high case fatality rate in
the low and middle income countries; the Unites Nations in 2012
acknowledged that the rising burden of NCDs is one of the serious
challenges to sustainable development in the 21st century.
3,15,25,37,38
The country wise statistics of the WHO on non-communicable dis-
eases (NCDs) estimate that in India, the non-communicable diseases
account for around 53% of the total deaths, among which CVDs have a
major share of 24%.
34
With the turn of the century, cardiovascular
diseases (CVDs) have become the leading cause of mortality in India.
26
The Global Status on NCDs Report (2010) reported that there were more
than 2.5 million deaths from CVD in India in 2008, two-thirds due to
Coronary heart disease (CHD) and one-third due to stroke.
29,35
Studies
* Corresponding author. Centre of Social Medicine and Community Health, Jawaharlal Nehru University, Delhi, 110067, India.
E-mail addresses: jhumkikundu16@gmail.com (J. Kundu), sampurna34@gmail.com (S. Kundu).
Contents lists available at ScienceDirect
Clinical Epidemiology and Global Health
journal homepage: www.elsevier.com/locate/cegh
https://doi.org/10.1016/j.cegh.2021.100937
Received 30 October 2021; Received in revised form 4 December 2021; Accepted 9 December 2021
Clinical Epidemiology and Global Health 13 (2022) 100937
2
show that compared to the people of European ancestry, CVD affects
Indians at least a decade earlier and in their most productive midlife
years.
15,37
CVD prevalence appears to be most closely associated to a countrys
epidemiological transition stage,
24
particularly when high disease rates
in middle age persist into later life. According to a few population based
surveys, the prevalence of CVD in 2003 in rural India was estimated to
be 34% and 810% in urban areas.
7,10
As per Global burden of disease
study 2010, the age-standardized CVD death rate of 272 per 100 000
population in India is higher than the global average of 235 per 100 000
population.
8
CVD mortality rates vary signicantly by age and gender.
The WHOs India report shows that age-adjusted CVD mortality rates are
higher for men than women (349 per 100,000 among men and 265 per
100,000 among women).
44
These rates are two to three times higher as
compared to those in the United States, where mortality rate for men are
170 per 100,000 and 108 per 100,000 among women.
36
In India, more
than 10.5 million deaths occur annually, and it was reported that CVD
led to 20.3% of these deaths in men and 16.9% of all deaths in women.
9
A global CVD epidemic is rapidly evolving, with the burden of dis-
ease shifting. CVD currently kills twice as many people in developing
countries as it does in developed countries. Conventional risk factors
account for the great majority of CVD cases.
41
Many epidemiological
studies of cardiovascular risk factors in the mid and late twentieth
century found that the risk factors are higher in upper SES persons than
in lower SES subjects (Sapru, 2006).However, some studies reported
that risk factors could be more in poor, especially where illiteracy is
high.
11
Age plays a vital role in the deterioration of cardiovascular
functionality, resulting in an increased risk of cardiovascular disease
(CVD) in older adults
4
and.
22
However, sex differences are also
frequently perceived in aging adults regarding both onset and preva-
lence of CVD.
6
Diabetes is a major predisposing factor for developing
CVD in the aging population.
12
DCM (diabetic cardiomyopathy) de-
scribes heart disease, which develops primarily due to diabetes.
32
Adults
with diabetes historically have a higher prevalence rate of CVD than
adults without diabetes.
30
The risk of CVD increases continuously with
rising fasting plasma glucose levels, even before reaching levels suf-
cient for a diabetes diagnosis.
31
Some epidemiological evidence also indicates that CVD is associated
with behavioural risk factors like smoking, alcohol use, low physical
activity levels, and insufcient vegetable and fruit intake. In elderly
persons, hypertension has been found to be an independent risk factor
for acute myocardial infarction and stroke.
23,39
There is substantial
epidemiologic evidence for the familial aggregation of CVD. Researchers
from the Framingham Study reported that having CVD in at least one
parent doubled the 8-year risk of CVD among men and increased the risk
among women by 70%.
17
In order to develop and implement an effective strategy for preven-
tion and treatment of CVD in older people, it is necessary to have a more
comprehensive understanding of a wide range of CVD risk factors and
the factors relevant to this population. However, few studies focused on
the older people.
2,16
Therefore, the present study tries to assess the
prevalence of CVD and its attributable risk factors among the older
adults in India.
2. Data & methods
The current study used data from Longitudinal Aging Study in India
(LASI Wave 1), a national survey of scientic investigation of the health,
economics, and social determinants and consequences of population
aging in India. It is the worlds largest and Indias rst longitudinal
aging study. The LASI is designed to simultaneously generate data, raise
awareness of older peoples health issues, and inform public policies in
India and its states. The LASI provides a great opportunity to examine
how different healthcare policies and institutions inuence healthcare
utilization and health outcomes using innovative and comparable
measures of health, including the direct assessment of biological
measures. By the conventional practice for other population-based sur-
veys, the LASI sampling frame included only the household population.
The LASI (Wave 1)2017-18 dataset comprised 72,250 individuals aged
18 years. However, a total of 65562 data of participants aged 45 years
were included in the analysis of this study.
2.1. Variable description
Dependent variable: The dependent variable used for the study was
cardiovascular disease for multivariate analysis. Cardiovascular diseases
(CVDs) are a group of disorders of the heart and blood vessels. They
include hypertension, stroke, and chronic heart diseases such as rheu-
matic heart disease, congenital/structural disorder. The self-reported
prevalence of CVDs presented in this section was calculated by consid-
ering any one of the self-reported diagnosed conditions of hypertension,
stroke, and chronic heart diseases.
Independent variable: The following variables are used as under-
lying factors.
Socio-demographic factors: Sex of the respondents (male and fe-
male), age (4554, 5564,65-69 and 70+years), place of residence
(Rural and Urban), religion (Hindu, Muslim, Christian, and others),
Caste (SC, ST, OBC, Others), marital status (currently married, widowed,
and others (divorced/separated), education Categorized as Not
educated, up to Primary, up to Secondary, Secondary and above,
working status categorized as currently working worked in the past but
currently not working and never worked, the monthly per-capita quin-
tile (MPCE) characterized as poorest, poor, middle, richer and richest.
Genetic factors: Family history of CVD.
Behavioural factors: Physical activity (categorized as every day, at
least once a month and never worked).
Other risk factors: Diabetes and high cholesterol.
2.2. Statistical methods
Statistical analyses conducted using STATA version 14.2 include bi-
variate analysis and multivariate analysis. The prevalence of self-
reported diagnosed CVD is presented by sex, place of residence, age,
level of education, social group, religion, marital status, monthly per
capita expenditure, Physical activity, family history of CVD in India for
201718 pertaining to the Longitudinal aging study in India (LASI),
Wave 1.
Binary Logistic regression was carried out between CVD and its
associated risk factors. The dependent variable, CVD is was dichotomous
(yes/no), and the independent variables were the associated risk factors
of CVD like Sex, place of residence, age, physical activity, family history
of CVD etc. to check the independent effect on CVD. The logistic
regression model is as follows:
Logit (Y) = ln (p/1p) = ɑ+ß1x1+ß2x2+
Where p is the probability of the event and ɑ is the intercept, β1 are
regression coefcients; xi is set of predictors, and
ε
is an error term.
3. Results
Table 1 presents the self-reported prevalence of diagnosed CVDs
among older adults in India by background characteristics. Overall, the
self-reported prevalence of diagnosed CVDs was 29.4% for older adults
age 45 and above. The prevalence rate increased with age from 22% in
4554 to 38% in age 70 and above. Among the older adults, the self-
reported prevalence of diagnosed CVDs was higher among women
(32%) than men (26%), and it is much higher among those residing in
urban areas (40%) than in rural areas (25%). The self-reported preva-
lence of diagnosed CVDs increased with the level of education from 26%
among those with no schooling to 34% in those with secondary and
above education.
J. Kundu and S. Kundu
Clinical Epidemiology and Global Health 13 (2022) 100937
3
Similarly, the prevalence of CVD increased with the MPCE quintile
from 23% in the poorest quintile to 38% in the richest quintile. The
prevalence of Cardiovascular disease was higher among the other caste
(35%) compared to scheduled caste, scheduled tribes, and other back-
ward castes (OBC). Inconsistency with the result of Table 1, the preva-
lence of self-reported diagnosed CVD was higher among other religions
(38%) than Hindu, Muslim, and Christians. For instance, the prevalence
of CVD is signicantly low among respondents who reported currently
working (20%). The analysis revealed that older adults with diabetes
(66%) and cholesterol (68%) had a higher prevalence of CVD. However,
there is a graded inverse association between physical activity and the
prevalence of the cardiovascular disease. The prevalence of CVD was
comparatively high among those individuals who never engage in any
activity (35%). However, the analysis revealed that older adults with a
family history of CVD have a higher prevalence of diagnosed CVD
(44%).
Table 2 shows the Odds ratios for the likelihood of CVD by risk
factors. Analysis reveals that respondents of 5564 age groups were 1.5
times (OR 1.48, 95% CI 1.4181.553), and respondents of 6569 and
70+age groups are 2 (OR 2.04, 95% CI 1.9322.163) and 2.3 times
(OR2.256, 95% CI2.1442.375) more likely to suffer from CVD than
4554 age groups. Sex is another inherent risk factor in aging adults,
given that older females are reported to 1.3 times (OR1.35, 95% CI
1.3031.403)more likely to suffer from CVD than age-matched men. The
analysis also revealed that respondents in the urban area had a signi-
cantly greater risk factor for CVD. Older adults belong to urban area
were 1.5 times (OR 1.46, CI 95% 1.4071.517)more likely to suffer from
CVD. Physical inactivity has been revealed to be a major cause of CVD.
Diabetes (OR 0.24,95% CI 0.230.26)and high cholesterol (OR 0.22, CI
95% CI 0.2060.253)had a stronger association with CVD among older
adults supporting the nding that patients with diabetes have approxi-
mately twice the risk of stroke than the non-diabetics.
13
Additionally,
the study also revealed that the risk of having CVD was 0.5 times (OR
0.507,95% CI 0.4660.552) less among individuals without a family
history of CVD.
Table 1
Prevalence of Cardiovascular disease of (45+) older adult population in India by
its background characteristics, LASI (Wave 1, 201718), (N =65562).
Background Characteristics CVD Total Chi-
square
Yes No p value
Age-group
4554 4979
(21.7)
17936
(78.3)
22,914
5564 5778
(29.5)
13784
(70.5)
19,562
6569 3373
(35.8)
6050
(64.2)
9,423 0.000
70+5158
(37.8)
8505
(62.3)
13663
Sex
Male 7812
(25.9)
22307
(74.1)
30119 0.000
Female 11476
(32.4)
23967
(67.6)
35443
Place of residence
Rural 11104
(24.7)
33826
(75.3)
44,930 0.000
Urban 8184
(39.7)
12448
(60.3)
20,632
Religion
Hindu 15087
(28.1)
38651
(71.9)
53,738 0.000
Muslim 2769
(36.7)
4780
(63.3)
7,549
Christian 569 (28.2) 1420
(71.4)
1990
Others* 863 (37.8) 1422
(62.2)
2285
Social group
Schedule caste 3318
(26.7)
9119
(73.3)
12,437 0.0000
Schedule tribe 905 (16.2) 4676
(83.8)
5,581
Other backward class (OBC) 8715
(29.5)
20784
(70.5)
29,499
None of the above 5471
(34.8)
10245
(65.2)
15,715
Marital Status
Currently married 13196
(27.4)
34893
(72.6)
48,089
Widowed 5668
(36.4)
9885
(63.6)
15,553 0.000
Others** 424 (22.1) 1496
(77.9)
1,920
Education Level
No schooling 8679
(26.2)
24505
(73.9)
33184
Up to primary 4707
(31.3)
10352
(68.7)
15058
Up to secondary 3629
(34.0)
7044
(66.0)
10673
Secondary & above 2273
(34.2))
4371
(65.8)
6643 0.000
Working status
Currently working 6116
(20.2)
24142
(79.8)
30,258
worked in past but currently
not working
6823
(37.5)
11371
(62.5)
18,194 0.000
never worked 6349
(37.1)
10761
(62.9)
17,110
MPCE
Poorest 3117
(22.8)
10561
(77.2)
13,678
Poorer 3659
(26.3)
10263
(73.7)
13,923 0.000
Middle 3850
(28.7)
9582
(71.3)
13,432
Richer 4147
(32.6)
8587
(67.4)
12,734
Richest 4514
(38.2)
7281
(61.7)
11,796
Table 1 (continued )
Background Characteristics CVD Total Chi-
square
Yes No p value
Ever diagnosed diabetes
Yes 5349
(66.3)
2721
(33.7)
8,070 0.000
No 13970
(24.4)
43341
(75.6)
57,311
Ever diagnosed high cholesterol
Yes 1015
(68.0)
478 (32.0) 1,493 0.000
No 18304
(28.7)
45593
(71.4)
63,897
Physical activity
Everyday 3613
(22.1)
12763
(77.9)
16,377
Atleast once a month 2227
(21.8)
7970
(78.2)
10,197 0.000
Never 13351
(34.8)
25069
(65.3)
38,419
Family history of CVD
Yes 1251
(43.8)
1608
(56.2)
2859
No 17973
(28.9)
44223
(71.1)
62196 0.000
India 19288
(29.4)
46274
(70.6)
65562
Note:Religion; others *(Sikh, Buddhist/neo-Buddhist, Jain, Jewish, Parsi/
Zoroastrian, others) Marital status; others** (Divorced, Separated, Deserted,
Live-in-relationship, never-married.
J. Kundu and S. Kundu
Clinical Epidemiology and Global Health 13 (2022) 100937
4
4. Discussion
The present study tries to present the prevalence of cardiovascular
diseases and (hypertension, heart disease, and stroke) and the pertinent
risk factors among older adults in India. The study indicated that the
prevalence of CVD tended to increase with age. With aging, there is an
incremental acquisition of several CVD risk factors in an individuals
lifespan.
5
Although CVD remains the leading cause of death of both
women and men in India, there are considerable gender differences in
the prevalence of CVDs. The study indicated that women were more
likely to have CVD than men.This is also line with the study by
40
that
females have died from cardiovascular disease at a higher rate than
males. Despite the fact that women develop heart disease 10 years later
than males, they are more likely to suffer from a heart attack. It is
estimated that 35% of heart attacks in women go unrecognised or
unreported.
This is further supported by the researcher who state that Women
outnumber men in terms of living with and dying from CVD and stroke,
as well as the number of hospital discharges for heart failure and stro-
ke.
27
Sex differences in CVD prevalence largely reect sex differences in
Indian demographics. Because female sex is related to a longer life ex-
pectancy than male, women comprised a larger share of the elderly
population in which the prevalence of CVD is greatest. Along with that
the risk of cardiovascular disease in women is often underestimated due
to the misperception that women are more ‘protectedthan men against
CVD. The neglect of CVD among women leads to less aggressive treat-
ment strategies.
18
The present study showed that the place of residence is signicantly
related to the prevalence of CVD. Older adults residing in rural areas had
a lower chance of having CVD than urban areas. This is further sup-
ported by researchers who state that urban population had higher
prevalence of CVDs as compared to rural population. Risk factor prev-
alence from slum/peri-urban areas lay somewhere in between the urban
and rural population, but more inclined towards urban trends.
42
The study also revealed that high cholesterol, diabetes, were key risk
factors for CVD supporting the nding that adults with diabetes are
about twice as likely to die from heart disease or stroke as people
without diabetes (National diabetes statistical report, 2014).Further
studies have also indicated that Cardiovascular disease (myocardial
infarction, stroke, and peripheral vascular disease) is twofold more
common in people with type 2 diabetes (T2D), and it is the leading cause
of death in T2D patients.
19
The study showed that CVD prevalence was higher among the
physically inactive older adults, and this difference was statistically
signicant (p <0.001).This is line with the study by
1
who stated that
physical inactivity increases a persons chances of being overweight, of
having high blood pressure and of developing other conditions that
make cardiovascular disease more likely.Regular, moderate to vigorous
physical activity assists in reducing the risk of cardiovascular disease.
Participation in 150 min of physical activity of moderate intensity per
week was estimated to alleviate Ischemic heart disease by about 30%
and diabetes risk by 27% (WHO.2007). The study indicated that most of
the individuals with a signicant family history of heart dis-
ease/stroke/hypertension were more likely to develop CVD them-
selves.
14
in their study found that the individuals with a family history
(FH), perceived their risk for heart disease to be about twice as high as
individuals without a FH (p <0.001).
5. Conclusion
In conclusion, the study provided a representative prevalence of CVD
and relevant risk factors among older adult population in India. The high
prevalence of CVD risk factors among older adults manifested alarming
public health concerns and a future health demand. Implementational
strategies are required for reducing CVD risk among elderly by focussed
promotion of physical activities and early detection of CVDs based on
family history. It creates a threat if health promotion and awareness
programs are not well designed.
Funding
The authors received no nancial support for the research, author-
ship and/or publication of this article.
Availability of data and material
This research work was performed based on secondary data which is
freely available upon request at IIPS, India website (Source of data:htt
ps://www.iipsindia.ac.in/lasi).
Ethics approval & consent to participate
This research does not have an ethical code because this research
work was performed based on secondary data which is freely available
upon request at IIPS, India website (Source of data:https://www.iipsi
ndia.ac.in/lasi) and thus author does not require any ethical clearance
and consent to participate.
Consent for publication
Not applicable.
CRediT authorship contribution statement
Jhumki Kundu: Conceptualization, Methodology, Formal analysis,
Resources, Writing original draft, Visualization. Sampurna Kundu:
Writing review & editing, All authors read and approved the nal
manuscript.
Declaration of competing interest
The authors declared no potential conicts of interest concerning the
research, authorship and/or publication of this article.
Table-2
Results of Binary Logistic regression of risk factors of Cardiovascular disease of
(45+) older adult population in India, LASI (WAVE-1,201718), (N =65562).
Risk factors of cardiovascular Odds ratio 95% condence interval
Age- group
4554 ®
55-64 1.484*** [1.418,1.553]
65-69 2.045*** [1.932,2.163]
70+2.256*** [2.144,2.375]
Sex
Male ®
Female 1.353*** [1.303,1.403]
Place of residence
Rural ®
Urban 1.461*** [1.407,1.517]
Diabetes or blood sugar
Yes ®
No 0.246*** [0.234,0.259]
High cholesterol
Yes®
No 0.228*** [0.206,0.253]
Physical activity
everyday ®
Once in a month 1.073* [1.008,1.142]
never 1.379*** [1.315,1.445]
Family history of cardiovascular disease
Yes®
No 0.507*** [0.466,0.552]
Note: ® Reference category,*p <0.05, **p <0.01, ***p <0.001.
J. Kundu and S. Kundu
Clinical Epidemiology and Global Health 13 (2022) 100937
5
Acknowledgements
The authors cordially acknowledge International Institute for Pop-
ulation Sciences (IIPS) for providing us the LASI Wave 1 dataset for
conducting the study.
References
1Bijnen FC, Caspersen CJ, Mosterd WL. Physical inactivity as a risk factor for coronary
heart disease: a WHO and International Society and Federation of Cardiology
position statement. Bull World Health Organ. 1994;72(1):1.
2Chiu HC, Mau LW, Chang YY, Chang HY, Lee TK, Liu HW. Risk factors for
cardiovascular disease in the elderly in Taiwan. Kaohsiung J Med Sci. 2004;20(6):
279286.
3Clark H. NCDs: a challenge to sustainable human development. Lancet (Lond. Engl.).
2013 Feb 12;381(9866):510511.
4Curtis AB, Karki R, Hattoum A, Sharma UC. Arrhythmias in patients80 years of
age: pathophysiology, management, and outcomes. J Am Coll Cardiol. 2018;71(18):
20412057.
5Dhingra R, Vasan RS. Biomarkers in cardiovascular disease: statistical assessment
and section on key novel heart failure biomarkers. Trends Cardiovasc Med. 2017;27
(2):123133.
6Garcia M, Mulvagh SL, BaireyMerz CN, Buring JE, Manson JE. Cardiovascular
disease in women: clinical perspectives. Circ Res. 2016;118(8):12731293.
7Ghaffar A, Reddy KS, Singhi M. Burden of non-communicable diseases in South Asia.
BMJ. 2004 Apr 1;328(7443):807810.
8 Global Burden Of Diseases. GBD prole: India. fromHealthdata.orgwebsite: http://
www.healthdata.org/sites/default/files/files/country_profiles/GBD/ihme_gbd_count
ry_report_india.pdf; 2021.
9Gupta R, Mohan I, Narula J. Trends in coronary heart disease epidemiology in India.
Ann. Global Health. 2016 Mar 1;82(2):307315.
10 Gupta R. Burden of Coronary Heart Disease in India. Indian heart J; 2005.
11 Gupta R, Gupta VP, Ahluwalia NS. Educational status, coronary heart disease, and
coronary risk factor prevalence in a rural population of India. BMJ. 1994;309(6965):
13321336.
12 Halter JB, Musi N, Horne FM, Crandall JP, Goldberg A, Harkless L, High KP. Diabetes
and cardiovascular disease in older adults: current status and future directions.
Diabetes. 2014;63(8):25782589.
13 Hill MD. Stroke and diabetes mellitus. Handb Clin Neurol. 2014;126:167174.
14 Hunt K, Davison C, Emslie C, Ford G. Are perceptions of a family history of heart
disease related to health-related attitudes and behaviour? Health Educ Res. 2000;15
(2):131143.
15 Joshi R, Cardona M, Iyengar S, et al. Chronic diseases now a leading cause of death in
rural Indiamortality data from the Andhra Pradesh Rural Health Initiative. Int J
Epidemiol. 2006 Dec 1;35(6):15221529.
16 Li CY, Han HR, Kim J, Kim MT. Factors related to risk of cardiovascular disease
among older Korean Chinese with hypertension. Asian Nurs Res. 2011;5(3):164169.
17 Lloyd-Jones DM, Nam BH, DAgostinoSr RB, et al. Parental cardiovascular disease as
a risk factor for cardiovascular disease in middle-aged adults: a prospective study of
parents and offspring. JAMA. 2004;291(18):22042211.
18 Maas AH, Appelman YE. Gender differences in coronary heart disease. Neth Heart J.
2010;18(12):598603.
19 Morrish NJ, Wang SL, Stevens LK, Fuller JH, Keen H. Mortality and causes of death in
the WHO multinational study of vascular disease in diabetes. Diabetologia. 2001;44
(2):S14S21.
20 CDC, National Centers for Disease Control and Prevention. National Diabetes Statistics
Report: Estimates of Diabetes and its Burden in the United States, 2014.. Atlanta, GA: U.S.
Department of Health and Human Services; 2014.
21 World Health Organization (2021). Noncommunicable Diseases. Retrieved
September 2, 2021, from WHO website: https://www.who.int/news-room/fact
-sheets/detail/noncommunicable-diseases.
22 North BJ, Sinclair DA. The intersection between aging and cardiovascular disease.
Circ Res. 2012;110(8):10971108.
23 Odonnell MJ, Xavier D, Liu L, Zhang H, Chin SL, Rao-Melacini P, Yusuf S. Risk
factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the
INTERSTROKE study): a case-control study. Lancet. 2010;376(9735):112123.
24 Omran A. The Epidemiologic Transition: A Theory of the Epidemiology of Population
Change. 1971.
25 Ralston J, Reddy KS, Fuster V, Narula J. Cardiovascular diseases on the global
agenda: the United Nations high level meeting, sustainable development goals, and
the way forward. Global Heart. 2016 Dec 1;11(4):375379.
26 Reddy KS, Shah B, Varghese C, Ramadoss A. Responding to the threat of chronic
diseases in India. Lancet. 2005 Nov 12;366(9498):17441749.
27 Roger VL, Go AS, Lloyd-Jones DM, Adams RJ, Berry JD, Brown TM, Turner MB.
Heart disease and stroke statistics2011 update: a report from the American Heart
Association. Circulation. 2011;123(4):e18e209.
28 Roth GA, Mensah GA, Johnson CO, et al. Global burden of cardiovascular diseases
and risk factors, 19902019: update from the GBD 2019 study. J Am Coll Cardiol.
2020;76(25):29823021.
29 Sapru RP. An overview of cardiovascular diseases in India. Preventive cardiology: an
introduction; 1991:6986.
30 Sarwar, N., Gao, P., KondapallySeshasai, S. R., Gobin, R., Kaptoge, S., & Di
Angelantonio, E. Diabetes mellitus, fasting blood glucose concentration, and risk of
vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet
[Internet]. 2.
31 Singh GM, Danaei G, Farzadfar F, et al. The age-specic quantitative effects of
metabolic risk factors on cardiovascular diseases and diabetes: a pooled analysis.
PLoS One. 2013;8(7), e65174.
32 Toedebusch R, Belenchia A, Pulakat L. Diabetic cardiomyopathy: impact of biological
sex on disease development and molecular signatures. Front Physiol. 2018;9:453.
33 UNAIDS, World Health Organization. Prevention of Cardiovascular Disease. Pocket
Guidelines for Assessment and Management of Cardiovascular Risk. Africa: Who/Ish
Cardiovascular Risk Prediction Charts for the African Region. WHO; 2007.
34 WHO. Non- Communicable Diseases Country Prole: India. 2010.
35 World Health Organization. Global Status Report of NCD, 2010. Geneva: World Health
Organization; 2011.
36 World health organization. Global Status Report on Alcohol and Health 2014. Geneva,
Switzerland: World health organization; 2014.
37 Xavier D, Pais P, Devereaux PJ, Xie C, Prabhakaran D, et al. Treatment and outcomes
of acute coronary syndromes in India (CREATE): a prospective analysis of registry
data. Lancet. 2008;371(9622):14351442.
38 Yusuf S, Rangarajan S, Teo K, et al. Cardiovascular risk and events in 17 low-,
middle-, and high-income countries. N Engl J Med. 2014 Aug 28;371(9):818827.
39 Yusuf S, Hawken S, ˆ
Ounpuu S, Dans T, Avezum A, Lanas F, INTERHEART Study
Investigators. Effect of potentially modiable risk factors associated with myocardial
infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;
364(9438):937952.
40 Giardina EG. Heart disease in women. Int J Fertil Womens Med. 2000;45(6):350357.
41 Gaziano TA. Cardiovascular disease in the developing world and its cost-effective
management. Circulation. 2005;112(23):35473553.
42 Nag T, Ghosh A. Cardiovascular disease risk factors in Asian Indian population: a
systematic review. J Cardiovasc Dis Res. 2013;4(4):222228.
43 Miranda JJ, Barrientos-Guti´
errez T, Corvalan C, et al. Understanding the rise of
cardiometabolic diseases in low-and middle-income countries. Nat Med. 2019;25
(11):16671679.
44 Kumar AS, Sinha N. Cardiovascular disease in India: a 360 degree overview. Med J
Armed Forces India. 2020;76(1):1.
J. Kundu and S. Kundu
... The World Health Organization (WHO) estimates that in 2019, approximately 17.9 million individuals succumbed to CVDs, constituting 32% of all deaths worldwide [6]. In India, key risk factors for CVDs include high cholesterol, hypertension (HT), obesity, poor diet, diabetes, and sedentary lifestyle [7]. ...
... On the other hand, there is a clear negative relationship between physical activity levels and the prevalence of CVDs. In other words, the more physically active an older adult is, the less likely they are to have been diagnosed with CVD [7]. Another study reported that in India, the prevalence of self-reported risk factors for CVDs among older adults was 21 out of 100 people. ...
Article
Full-text available
Cardiovascular diseases (CVDs) constitute an important cause of morbidity and mortality globally, and India is no exception to this trend. With the ongoing aging of the population in India, there is a notable surge in the prevalence and impact of CVDs among older adults. This review is aimed at providing a comprehensive overview of the current knowledge concerning the prevalence, risk factors, and management of CVDs in the context of Indian older adults. The incidence of CVDs in India is not only alarming but also exhibits an upward trajectory with advancing age. Primary risk factors contributing to the elevated incidence among older adults include hypertension (HT), diabetes, dyslipidemia, obesity, smoking, a sedentary lifestyle, and poor dietary habits. Additionally, stress and genetic predisposition emerge as noteworthy contributors to CVDs in this population. Effectively identifying and managing these risk factors among older adults in India is imperative to alleviate the burden of these diseases and enhance overall quality of life. Strategies aimed at mitigating the impact of CVDs in the country necessitate a comprehensive approach, integrating lifestyle interventions, public health initiatives, and a robust healthcare system. In summary, CVDs represent a significant health concern in both rural and urban areas of India. However, variations exist in the prevalence, risk factors, and accessibility to healthcare between these regions. Therefore, addressing the prevalence of CVDs in India necessitates a complex, multidimensional strategy that takes into account the unique opportunities and challenges that come with living in both rural and urban areas.
... The World Health Organization (WHO) estimates that in 2019, approximately 17.9 million individuals succumbed to CVDs, constituting 32% of all deaths worldwide [6]. In India, key risk factors for CVDs include high cholesterol, hypertension (HT), obesity, poor diet, diabetes, and sedentary lifestyle [7]. ...
... On the other hand, there is a clear negative relationship between physical activity levels and the prevalence of CVDs. In other words, the more physically active an older adult is, the less likely they are to have been diagnosed with CVD [7]. Another study reported that in India, the prevalence of self-reported risk factors for CVDs among older adults was 21 out of 100 people. ...
... 25 A very large cohort study from India with a sample size of around 65 000 people demonstrated that the prevalence of CVD is high in India and women when compared with men have a higher risk of developing CVD. 26 Results from the same cohort study revealed that physical inactivity and obesity increased the likelihood of CVD by 22% and 60%, respectively. 27 Lifestyle-based interventions are the need of the hour to address these risk factors so that their impact on cognitive performance can be reduced. ...
Article
Full-text available
Objective The burden of cardiovascular risk factors is increasing in India, which, in turn, can adversely impact cognition. Our objective was to examine the effect of cardiovascular risk factors measured by Framingham Risk Score (FRS) on cognitive performance among a cohort of healthy, ageing individuals (n=3609) aged ≥45 years from rural India. Design A cross-sectional analysis. Setting A rural community setting in southern India. Participants Healthy, ageing, dementia-free participants, aged 45 years and above, belonging to the villages of Srinivaspura (a rural community located around 100 km from Bangalore, India), were recruited. Primary outcome measures Using a locally adapted, validated, computerised cognitive test battery, we assessed cognitive performance across multiple cognitive domains: attention, memory, language, executive functioning and visuospatial ability. Results The median (IQR) age of the sample was 57 (50.65) and 50.5% were women. Multiple linear regression analysis showed that participants with higher FRS performed poorly in attention (visual attention (β=−0.018, p=0.041)), executive functioning (categorical fluency (β=−0.064, p<0.001)), visuospatial ability (form matching (β=−0.064, p<0.001) and visuospatial span (β=−0.020, p<0.001)), language (reading and sentence comprehension (β=−0.010, p=0.013), word comprehension (β=−0.021, p<0.001) and semantic association (β=−0.025, p<0.001)), and memory (episodic memory IR (β=−0.056, p<0.001), episodic memory DR (β=−0.076, p<0.001) and name-face association (β=−0.047, p<0.001)). Conclusion Increased cardiovascular risk as evidenced by FRS was associated with poorer cognitive performance in all cognitive domains among dementia-free middle-aged and older rural Indians. It is imperative to design and implement appropriate interventions (pharmacological and lifestyle-based) for cardiovascular risk reduction and thereby, prevent or mitigate accelerated cognitive impairment in ageing individuals.
Article
Objectives Rapid changes in India’s population and epidemiology are being brought about by Noncommunicable diseases, which significantly increase morbidity, mortality, and disability in both urban and rural populations, as well as in all socioeconomic groups. The aim of this study was to assess the prevalence of Cardiovascular Risk Factors (CVRF) in the rural population of Puducherry. Material and Methods This cross-sectional descriptive study was conducted in Puducherry’s rural field practice area, which is connected to Aarupadai Veedu Medical College & Hospital (AVMC&H). A total of one thousand rural residents, ages 40 to 75, comprised the samples. With the aid of a modified WHO steps approach, a structured questionnaire containing physical measurements, CVRF information, and sociodemographic details was used to collect the data. SPSS version 28.0 was used to analyse the data. The prevalence of CVRF was determined using percentages, and the degree of correlation between the rural population’s CVRF and their demographic characteristics were examined. Results The following behaviours have the highest prevalence of CVRF: smoking (28.3%), drinking alcohol (13.8%), not exercising (48%), consuming coffee (60.2%), tea (61.4%), artificial beverages (42.6%), nonvegetarian (98.1%), consuming insufficient amounts of fruits and vegetables (32%), insomnia (59.4%), being overweight (18.5%), class I obesity (6.4%), hypertension (25%) and diabetes mellitus (25.1%). The cardiovascular risk factors of the rural population, such as the use of tobacco products (p < 0.001), the consumption of coffee, tea, and artificial beverages (p < 0.001), the use of alcohol (p < 0.001), the non-vegetarian diet (p < 0.001), the insufficient intake of fruits and vegetables (p < 0.001), obesity (p = 0.001), Waist Hip Ratio (WHR) at risk (p < 0.001), hypertension (p < 0.001), and diabetes (p < 0.001), were strongly statistically significantly associated with demographic variables. Conclusion A significant proportion of Puducherry’s rural population has cardiovascular risk factors. It is imperative to reduce the prevalence of cardiovascular risk factors in the community by implementing lifestyle modifications that suppress risky behaviours at an early age.
Article
Full-text available
The aetiology of preterm cardiovascular disease formation appears different from that of traditional population. Within the ‘traditional’ population cardiovascular disease formation is driven by functional stressors (e.g., diet, smoking). Whereas preterm cardiovascular disease risk is driven by structural changes incurred at birth. Much of the proliferative growth in the developing heart and major vessels ceases at birth, leading to permanently reduced dimensions compared to their term-born cohort. These structural changes take a back seat to functional and clinical complications within the neonatal period, but become increasingly pronounced from adolescence, at which point functional decompensation can be observed. While the cause may differ from ‘traditional’ populations, the eventual disease outcomes do not, leading them to be an overlooked population. This means that aetiology, and thus, treatment options may be very different due to the underlying mechanisms. Here, we propose that the structural cause of preterm-associated cardiovascular disease is apparent and observable early in life. Understanding the differences in cardiovascular disease aetiology may therefore aid in the early treatment of preterm-associated cardiovascular disease risk.
Article
Full-text available
Introduction and Aim: Coronary artery disease (CAD) is a pathological process described by atherosclerosis plaque in the epicardial arteries. CAD is a chronic process that begins during adolescence and slowly progresses through life. Several traditional risk factors genetics and environmental, involve in the development of atherosclerosis process. This study was aimed to investigate the prevalence of CAD and its associated risk factors among the El Oued (Algeria) population. Materials and Methods: An epidemiological study was carried out on 23422 patients who suffered from cardiovascular diseases. The study of risk factors analysis was focused on 300 voluntary individuals, their origins from different El-Oued areas, and the CAD and metabolic syndrome patients selected from public and private health interests. All the information was obtained by a questionnaire. The risk of socio-clinical factors has been estimated by Binary Logistic regression was carried out between CVD and its associated risk factors. P < 0.05 from two-sided statistical tests was regarded as statistically significant. Results: Through the results presented in our study, we found that the clinical factors such as hypertension (OR=154.846, and; P =0.000), the group aged> 60 (OR=154.84, and; P =0.000 and chest pain (OR=42.667, and; P =0.000), present significant risk factors with CAD patients compared to healthy people (control), respectively, in contrast we show that the most dangerous Socioeconomic factors alcohol consumption and stress respectively for (OR=13.500= and; P =0.001), and obesity (OR=4.495= and; P =0.000), but we estimate that sport is important protective factors for the disease with OR=52.6, P 0.500) in the CAD patients compared to metabolic syndrome patients. Conclusion: The increasing prevalence of risk factors for coronary artery disease among the population has raised concerns for public health, which creates a health threat, especially with inadequate promotion and awareness programs.
Article
Background: Nattokinase (NK) is a naturally occurring fibrinolytic protease enzyme obtained from the traditional Japanese food called Natto and has several uses in the pharmaceutical and medical industries. Nowadays, the most often used thrombolytic agent in the clinical field is NK, in part because it is less expensive than other thrombolytic medicines. Objective: The objective of this study is to investigate the screening, isolation and characterization of the NK enzyme-producing Bacillus strain from fermented Soya beans. Methods: The sample of fermented soya beans were tested for the presence of fibrinolytic protease- producing bacteria, followed by the screening, extraction, characterization and clot lysis assays. Results: A total of three isolates were screened for caseinolytic activities by casein hydrolysis assay. Out of those isolates, MRS18 was found to be potent in producing the enzyme proteinase. To determine the taxonomy and phylogeny of these isolates, biochemical and molecular characterization has been carried out. Bacillus amyloliquiefaciens MRS18 has been found with the highest caseinolytic activity. The clot lysing ability of the potent strain Bacillus amyloliquiefaciens was found to be 61.7% after 120 min, and on further purification, by ammonium sulphate precipitation method, the lysis percentage was found to be 65.6 % after 120 min. Conclusion: From the results of the present study, we concluded that Bacillus amyloliquefaciens isolated from the fermented soya beans produced an NK enzyme that exhibits immense potential to lyse blood clots.
Article
Background:: People with HIV (PLHIV) face increased cardiovascular disease (CVD) risk due to inflammation and immune activation. Aging further amplifies this risk. Limited data exist on CVD risk in older PLHIV in India despite 2.14 million PLHIV with higher CVD risk factors. Methods:: In a cross-sectional study in Bihar, India, 73 PLHIV and 30 control participants were enrolled. Demographics, social factors, clinical information, and CVD risk factors were collected. HbA1c levels and lipid profiles were analyzed, and 10-year CVD risk scores were calculated using the Framingham risk score (FRS) and Qrisk3. Quality of life (QoL) was assessed using WHOQOL- HIV-BREF. Results:: Results showed higher LDL levels in non-HIV older participants and higher HDL levels in younger PLHIV participants. BMI differed significantly, with higher BMI in non-HIV older individuals and lower BMI in younger PLHIV individuals. Older PLHIV participants had significantly higher mean FRS and Q-Risk scores compared to older non-PLHIV and younger PLHIV groups. Among older PLHIV participants, six had higher CVD risk per FRS, while none in the other groups were classified as high CVD risk. Psychological, social relations and spirituality domains were highly deteriorated in older PLHIV, scoring 44.48, 42.72, and 41.2, respectively. The physical domain scored 57.6, and the environment scored 52.72 in the WHOQOL-HIV bref. Conclusion:: In conclusion, older PLHIV in Bihar, India, face higher CVD risk compared to younger PLHIV and non-HIV individuals. FRS and Q-Risk scores effectively assessed CVD risk, identifying higher risk in older PLHIV. Age and BMI were significant predictors of high CVD risk. These findings emphasize CVD risk assessment and tailored management for older PLHIV. The QoL assessment findings indicate moderate deterioration in psychological, social relations, and spirituality domains among older PLHIV individuals. These results suggest greater challenges in psychological well-being, social interactions, and spirituality compared to the overall sample. Further research with larger samples and longitudinal designs is needed to confirm and extend these findings.
Article
Full-text available
Cardiovascular diseases (CVDs), principally ischemic heart disease (IHD) and stroke, are the leading cause of global mortality and a major contributor to disability. This paper reviews the magnitude of total CVD burden, including 13 underlying causes of cardiovascular death and 9 related risk factors, using estimates from the Global Burden of Disease (GBD) Study 2019. GBD, an ongoing multinational collaboration to provide comparable and consistent estimates of population health over time, used all available population-level data sources on incidence, prevalence, case fatality, mortality, and health risks to produce estimates for 204 countries and territories from 1990 to 2019. Prevalent cases of total CVD nearly doubled from 271 million (95% uncertainty interval [UI]: 257 to 285 million) in 1990 to 523 million (95% UI: 497 to 550 million) in 2019, and the number of CVD deaths steadily increased from 12.1 million (95% UI:11.4 to 12.6 million) in 1990, reaching 18.6 million (95% UI: 17.1 to 19.7 million) in 2019. The global trends for disability-adjusted life years (DALYs) and years of life lost also increased significantly, and years lived with disability doubled from 17.7 million (95% UI: 12.9 to 22.5 million) to 34.4 million (95% UI:24.9 to 43.6 million) over that period. The total number of DALYs due to IHD has risen steadily since 1990, reaching 182 million (95% UI: 170 to 194 million) DALYs, 9.14 million (95% UI: 8.40 to 9.74 million) deaths in the year 2019, and 197 million (95% UI: 178 to 220 million) prevalent cases of IHD in 2019. The total number of DALYs due to stroke has risen steadily since 1990, reaching 143 million (95% UI: 133 to 153 million) DALYs, 6.55 million (95% UI: 6.00 to 7.02 million) deaths in the year 2019, and 101 million (95% UI: 93.2 to 111 million) prevalent cases of stroke in 2019. Cardiovascular diseases remain the leading cause of disease burden in the world. CVD burden continues its decades-long rise for almost all countries outside high-income countries, and alarmingly, the age-standardized rate of CVD has begun to rise in some locations where it was previously declining in high-income countries. There is an urgent need to focus on implementing existing cost-effective policies and interventions if the world is to meet the targets for Sustainable Development Goal 3 and achieve a 30% reduction in premature mortality due to noncommunicable diseases.
Article
Full-text available
Cardiovascular diseases (CVDs), principally ischemic heart disease (IHD) and stroke, are the leading cause of global mortality and a major contributor to disability. This paper reviews the magnitude of total CVD burden, including 13 underlying causes of cardiovascular death and 9 related risk factors, using estimates from the Global Burden of Disease (GBD) Study 2019. GBD, an ongoing multinational collaboration to provide comparable and consistent estimates of population health over time, used all available population-level data sources on incidence, prevalence, case fatality, mortality, and health risks to produce estimates for 204 countries and territories from 1990 to 2019. Prevalent cases of total CVD nearly doubled from 271 million (95% uncertainty interval [UI]: 257 to 285 million) in 1990 to 523 million (95% UI: 497 to 550 million) in 2019, and the number of CVD deaths steadily increased from 12.1 million (95% UI:11.4 to 12.6 million) in 1990, reaching 18.6 million (95% UI: 17.1 to 19.7 million) in 2019. The global trends for disability-adjusted life years (DALYs) and years of life lost also increased significantly, and years lived with disability doubled from 17.7 million (95% UI: 12.9 to 22.5 million) to 34.4 million (95% UI:24.9 to 43.6 million) over that period. The total number of DALYs due to IHD has risen steadily since 1990, reaching 182 million (95% UI: 170 to 194 million) DALYs, 9.14 million (95% UI: 8.40 to 9.74 million) deaths in the year 2019, and 197 million (95% UI: 178 to 220 million) prevalent cases of IHD in 2019. The total number of DALYs due to stroke has risen steadily since 1990, reaching 143 million (95% UI: 133 to 153 million) DALYs, 6.55 million (95% UI: 6.00 to 7.02 million) deaths in the year 2019, and 101 million (95% UI: 93.2 to 111 million) prevalent cases of stroke in 2019. Cardiovascular diseases remain the leading cause of disease burden in the world. CVD burden continues its decades-long rise for almost all countries outside high-income countries, and alarmingly, the age-standardized rate of CVD has begun to rise in some locations where it was previously declining in high-income countries. There is an urgent need to focus on implementing existing cost-effective policies and interventions if the world is to meet the targets for Sustainable Development Goal 3 and achieve a 30% reduction in premature mortality due to noncommunicable diseases.
Article
Full-text available
Diabetic cardiomyopathy refers to a unique set of heart-specific pathological variables induced by hyperglycemia and insulin resistance. Given that cardiovascular disease (CVD) is the leading cause of death in the world, and type 2 diabetes incidence continues to rise, understanding the complex interplay between these two morbidities and developing novel therapeutic strategies is vital. Two hallmark characteristics specific to diabetic cardiomyopathy are diastolic dysfunction and cardiac structural mal-adaptations, arising from cardiac cellular responses to the complex toxicity induced by hyperglycemia with or without hyperinsulinemia. While type 2 diabetes is more prevalent in men compared to women, cardiovascular risk is higher in diabetic women than in diabetic men, suggesting that diabetic women take a steeper path to cardiomyopathy and heart failure. Accumulating evidence from randomized clinical trials indicate that although pre-menopausal women have lower risk of CVDs, compared to age-matched men, this advantage is lost in diabetic pre-menopausal women, which suggests estrogen availability does not protect from increased cardiovascular risk. Notably, few human studies have assessed molecular and cellular mechanisms regarding similarities and differences in the progression of diabetic cardiomyopathy in men versus women. Additionally, most pre-clinical rodent studies fail to include female animals, leaving a void in available data to truly understand the impact of biological sex differences in diabetes-induced dysfunction of cardiovascular cells. Elegant reviews in the past have discussed in detail the roles of estrogen-mediated signaling in cardiovascular protection, sex differences associated with telomerase activity in the heart, and cardiac responses to exercise. In this review, we focus on the emerging cellular and molecular markers that define sex differences in diabetic cardiomyopathy based on the recent clinical and pre-clinical evidence. We also discuss miR-208a, MED13, and AT2R, which may provide new therapeutic targets with hopes to develop novel treatment paradigms to treat diabetic cardiomyopathy uniquely between men and women.
Article
Full-text available
Cardiovascular diseases, especially coronary heart disease (CHD), are epidemic in India. The Registrar General of India reported that CHD led to 17% of total deaths and 26% of adult deaths in 2001-2003, which increased to 23% of total and 32% of adult deaths in 2010-2013. The World Health Organization (WHO) and Global Burden of Disease Study also have highlighted increasing trends in years of life lost (YLLs) and disability-adjusted life years (DALYs) from CHD in India. In India, studies have reported increasing CHD prevalence over the last 60 years, from 1% to 9%-10% in urban populations and <1% to 4%-6% in rural populations. Using more stringent criteria (clinical ± Q waves), the prevalence varies from 1%-2% in rural populations and 2%-4% in urban populations. This may be a more realistic prevalence of CHD in India. Case-control studies have reported that important risk factors for CHD in India are dyslipidemias, smoking, diabetes, hypertension, abdominal obesity, psychosocial stress, unhealthy diet, and physical inactivity. Suitable preventive strategies are required to combat this epidemic.
Article
Increases in the prevalence of noncommunicable diseases (NCDs), particularly cardiometabolic diseases such as cardiovascular disease, stroke and diabetes, and their major risk factors have not been uniform across settings: for example, cardiovascular disease mortality has declined over recent decades in high-income countries but increased in low- and middle-income countries (LMICs). The factors contributing to this rise are varied and are influenced by environmental, social, political and commercial determinants of health, among other factors. This Review focuses on understanding the rise of cardiometabolic diseases in LMICs, with particular emphasis on obesity and its drivers, together with broader environmental and macro determinants of health, as well as LMIC-based responses to counteract cardiometabolic diseases. The rise of cardiometabolic diseases in low- and middle-income countries is tied to a multitude of environmental, social and commercial determinants, which are discussed in this Review along with a strategy to counteract those factors.
Article
Advances in medical care have led to an increase in the number of octogenarians and even older patients, forming an important and unique patient subgroup. It is clear that advancing age is an independent risk factor for the development of most arrhythmias, causing substantial morbidity and mortality. Patients ≥80 years of age have significant structural and electrical remodeling of cardiac tissue; accrue competing comorbidities; react differently to drug therapy; and may experience falls, frailty, and cognitive impairment, presenting significant therapeutic challenges. Unfortunately, very old patients are under-represented in clinical trials, leading to critical gaps in evidence to guide effective and safe treatment of arrhythmias. In this state-of-the-art review, we examine the pathophysiology of aging and arrhythmias and then present the available evidence on age-specific management of the most common arrhythmias, including drugs, catheter ablation, and cardiac implantable electronic devices.
Article
Cardiovascular disease (CVD) is a leading cause of death worldwide and continues to increase in prevalence compared to previous decades, in part because of the aging of the world population. Atherosclerotic CVD starts at a very young age and progresses over time allowing sufficient time for screening and early detection of the condition. Advances in biomarker research and developments related to CVD over the past 30 years have led to more sensitive screening methods, a greater emphasis on its early detection and diagnosis, and improved treatments resulting in more favorable clinical outcomes in the community. However, the use of biomarkers for different purposes in CVD remains an important area of research that has been explored by scientists over the years and many new developments are still underway. Therefore, a detailed description of all CVD biomarkers that are currently been used or investigated for future use in the field of cardiovascular medicine is out of scope for any review article. In the present review, we do not intend to replicate the information from previous exhaustive review on biomarkers, but highlight key statistical and clinical issues with an emphasis on methods to evaluate the incremental yield of biomarkers, including their clinical utility, a prerequisite before any putative novel biomarker is utilized in clinical practice. In addition, we will summarize information regarding recent novel heart failure biomarkers in current practice, which are undergoing scrutiny before they can be available for clinical use, and their impact on clinical outcomes.